


Scandion Oncology Revenue
Biotechnology Research • Copenhagen, Capital Region of Denmark, Denmark • 1-10 Employees
Scandion Oncology revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | $902,200 |
Key Contact at Scandion Oncology
Keld Flintholm Jørgensen
Independent Board Director
Company overview
| Headquarters | Fruebjergvej 3, Copenhagen, DK 2100, DK |
| Phone number | +4538102017 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Founded | 2017 |
| Employees | 1-10 |
| Socials |
About Scandion Oncology
Scandion Oncology A/S is a listed Danish biotechnology company with the mission to address one of the most important challenges in modern oncology - the effective treatment of cancer which has developed resistance towards existing cancer medicine. The company's first-in-class lead compound, SCO-101, is an add-on to chemotherapy and is currently in clinical phase I and II studies in cancer patients. The company also has several preclinical programs to build a broader pipeline of drugs for the treatment of drug resistant cancer diseases.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Scandion Oncology Tech Stack
Discover the technologies and tools that power Scandion Oncology's digital infrastructure, from frameworks to analytics platforms.
Web servers
Font scripts
Cookie compliance
JavaScript libraries
Tag managers
Programming languages
Miscellaneous
Blogs
UI frameworks
Analytics
Maps
Databases
Frequently asked questions
4.8
40,000 users



